What Does Patient-Centered Innovation Look Like in Precision Medicine?

During this engaging discussion, Dr. Sehnert will share insights on how organizations can better align scientific innovation with the needs of patients, including:

  • Lessons learned from developing first-in-class therapeutics
  • Starting with unmet patient needs and matching them to scientific opportunity
  • Designing clinical trials around outcomes that matter most to patients
  • Reducing patient burden while improving the study experience from start to finish
  • Building strong partnerships across sponsors, CROs, sites, investigators, and patients
  • Creating trust through communication, respect, and empathy to drive better science, better trials, and ultimately better medicines

Whether you’re involved in clinical development, operations, or strategic partnerships, this session will offer practical perspectives on advancing patient-centered innovation in precision medicine.

About The Speaker

Amy Sehnert, MD, FACC is Chief Medical Officer at Thryv Therapeutics, where she leads the development of innovative cardiovascular therapies. A physician-scientist and executive leader, she has more than 20 years of experience advancing novel medicines through clinical development, regulatory approval, and commercialization. Previously, Dr. Sehnert held senior leadership roles at Bristol Myers Squibb, leading global cardiovascular programs. She is passionate about translating scientific innovation into meaningful patient outcomes and is an active member of the Biotech CMO Sisterhood and the University of Minnesota Medical School Alumni Board.

Speaker

Amy Sehnert MD, FACC

Chief Medical Officer, Thryv Therapeutics

Join the live webinar and gain insights from our learning.

Register Now